• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli companies.

    Shavit Capital manages three separate private equity funds with over $125 million under management. These Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a
    company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Foamix Announces Positive Topline Results from Phase 2 Trial Evaluating FMX-1
    September 12, 2016
    ReWalk Exoskeleton Deemed Necessary as Medical Aid
    August 4, 2016
    ReWalk Reports Second Quarter 2016 Financial Results
    August 4, 2016
    Intec Pharma to Pursue Development of Accordion Pill for Cannabinoid Therapie
    August 4, 2016
    ReWalk Launches Post-Market Study with Stanford
    August 2, 2016
    Foamix Pharmaceuticals Announces Publication of Abstract on FDX-104 in the Tr
    May 31, 2016
    ReWalk Announces Collaboration with Harvard University’s Wyss Institute to
    May 17, 2016
    Foamix Names Dr. Stanley Hirsch as Chairman, and Dr. Dalia Megiddo as a Membe
    May 16, 2016
    Intec Pharma Nominates John Kozarich As Chairman Of Board
    May 16, 2016
    Foamix Reports First Quarter 2016 Financial Results and Provides Business Upd
    May 10, 2016